BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Thomson Reuters
TRI
$44.1B
| $6.44M | ﹤0.01% |
85,368
-36,903
| -30% | -$2.69M |
|
|
ZYXI
3427
DELISTED
Zynex
ZYXI
| $6.43M | ﹤0.01% |
899,287
+10,055
| +1% | +$88.4K |
|
|
AFI
3428
DELISTED
Armstrong Flooring, Inc.
AFI
| $6.41M | ﹤0.01% |
1,500,463
-42,089
| -3% | -$206K |
|
|
AC
3429
DELISTED
Associated Capital Group
AC
| $6.39M | ﹤0.01% |
163,771
+4,501
| +3% | +$169K |
|
|
RNET
3430
DELISTED
RigNet, Inc.
RNET
| $6.3M | ﹤0.01% |
954,775
+8,858
| +0.9% | +$53.1K |
|
3431
Golub Capital BDC
GBDC
$3.42B
| $6.28M | ﹤0.01% |
347,448
+14,022
| +4% | +$247K |
|
3432
GeoPark
GPRK
$612M
| $6.21M | ﹤0.01% |
281,988
+26,419
| +10% | +$501K |
|
|
LJPC
3433
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $6.19M | ﹤0.01% |
1,574,336
+120,937
| +8% | +$714K |
|
3434
Colony Bankcorp
CBAN
$467M
| $6.18M | ﹤0.01% |
374,686
+7,468
| +2% | +$118K |
|
|
PHAS
3435
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $6.11M | ﹤0.01% |
999,708
+79,666
| +9% | +$328K |
|
3436
Lifetime Brands
LCUT
$211M
| $6.07M | ﹤0.01% |
873,620
+2,492
| +0.3% | +$17.9K |
|
3437
Pembina Pipeline
PBA
$27.6B
| $6.03M | ﹤0.01% |
162,628
-35,162
| -18% | -$1.26M |
|
|
ISEE
3438
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.02M | ﹤0.01% |
701,527
+47,917
| +7% | +$171K |
|
|
PACD
3439
DELISTED
Pacific Drilling S.A. Common Shares
PACD
| $6.01M | ﹤0.01% |
1,474,016
-7,215
| -0.5% | -$22.6K |
|
3440
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
| $5.97M | ﹤0.01% |
223,444
-26,264
| -11% | -$704K |
|
3441
New Mountain Finance
NMFC
$732M
| $5.94M | ﹤0.01% |
432,263
+17,655
| +4% | +$239K |
|
|
RCA
3442
DELISTED
Ready Capital Corporation 7.00% Convertible Senior Notes due 2023
RCA
| $5.94M | ﹤0.01% |
221,598
+30,727
| +16% | +$832K |
|
3443
Maui Land & Pineapple Co
MLP
$344M
| $5.9M | ﹤0.01% |
524,461
+1,026
| +0.2% | +$10.9K |
|
3444
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.36B
| $5.9M | ﹤0.01% |
200,000
| – | – |
|
|
AXIA
3445
DELISTED
AXIA Energia
AXIA
| $5.88M | ﹤0.01% |
797,040
-49,900
| -6% | -$352K |
|
|
GCAP
3446
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $5.86M | ﹤0.01% |
1,483,386
+56,332
| +4% | +$242K |
|
3447
BioXcel Therapeutics
BTAI
$27.8M
| $5.85M | ﹤0.01% |
25,035
+5,750
| +30% | +$578K |
|
3448
First Guaranty Bancshares
FGBI
$159M
| $5.85M | ﹤0.01% |
295,611
+1,807
| +0.6% | +$32.3K |
|
3449
iShares MSCI Japan Value ETF
EWJV
$756M
| $5.82M | ﹤0.01% |
225,000
-55,000
| -20% | -$1.44M |
|
|
TYME
3450
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $5.8M | ﹤0.01% |
4,141,584
+130,711
| +3% | +$159K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.